Modular Genetics Designstes New Chief Financial Officer
Before being appointed in Modular, Mr Grimm was the senior vice president and chief financial officer of Prospect Therapeutics. In addition he has held executive management positions at
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.